Be A Voice Not An Echo

Article

A cancer survivor urges all of us to express our concerns, and assist each other through our individual and collective voices.

Recently, I was shopping with a friend and came across a pretty sign that stated, “Be a voice, not an echo.” We stared at each other, I said I had to buy it and she conceded “this is you!” Later, I found out that it is a quote by the great Albert Einstein.

I have been an advocate for people with disabilities my entire life, starting in my 20’s. I always become defensive if I perceive someone with a disability being made fun of or taken advantage if. Part of this is because I was bullied as a child in school, as a result of being the only person there with large ugly body aids. I later received a master's in rehabilitation counseling, a doctorate in counseling, and taught graduate classes on the American with Disabilities Act. I constantly am coaching people on their rights, have written several articles, and conducted workshops on assisting people with disabilities.

Along came my service hearing ear dog. I became an even stronger advocate when refused entry in public places and constantly being questioned about why I have her since hearing loss is an invisible disability. I even had one woman yell at me that I did not need a dog as much as her mother because my hearing was not as bad. Really!

Then along came cancer. Like most people diagnosed with this insidious disease, I spent a long time simply processing that I had an incurable and terminal kind of cancer and coped with how to go about fighting it. Then the chemo, side effects and the battle to just stay alive happened. Gradually, like most survivors, I figured out that I needed to take life day by day. All of us do, but cancer teaches us this even sooner.

I was stunned by tactless remarks made to me like, “I get tired too,” or “Well, you have already lived longer than you are supposed to.” I could not believe how people blurt things out without thinking.

After several years I began my writing and started to be honest about my feelings. The response I received from other survivors astounded me. We are expected as cancer “victims” (I use that word in quotes because I never say that) to be accepting, to be grateful, to be angelic with this disease. It is a burden to bear.

I found out from my oncologist about CURE® and took to it like a duck to water. Here was an entire group of people sounding off about how they really feel about cancer. They describe their emotions of anger, fear, bewilderment, sadness and much more.

My very first article was titled “Being Vulnerable With Cancer Is Ok.” I confessed on Facebook how scared I was and was overwhelmed by the love and support that came pouring out. I wrote about this experience. In all my writing, I have been honest about my trials and tribulations and tried to break the stereotype of the meek and angelic patient.

The cancer center where I go for my treatments contacted me after I complained to the CEO of the hospital about a problem. They shocked me when I was asked to be on the Patient Advisory Committee. I realized they did want to address problems and hear our voices. I became involved with my co-conspirators, a wonderful group of survivors who bonded immediately, as we presented suggestions for the new cancer center. I remember saying at one meeting that the laboratories needed to be changed because the present ones, well, sucked. They are small and cramped with a constant flow of traffic, in and out, offering no privacy. The others on the committee laughed, and then offered their own suggestions— we have been assured by the architects that things will be different.

I have learned along with several of these survivors not to be an echo and say what is expected. Rather be a voice. And that does not mean complaining just to vent, because that helps no one. However, we need to be honest about our feelings, share with other survivors, and when appropriate make solid suggestions to assist all of us. As a group, we are an even louder voice and this ultimately benefits every one of us!

Related Videos
Image of Meaghan Mooney at the 2024  Extraordinary Healer Award event.
Video 4 - "Current First-Line Treatment Options in CLL"
Video 3 - "Goals of Treatment for Patients With CLL"
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Related Content